I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Patients will be randomly assigned to get either brentuximab vedotin or placebo. The placebo will look like brentuximab vedotin, but has no medicine in it. Since the study is "blinded," patients and their doctors will not know whether a patient gets brentuximab vedotin or placebo.
b-cell lymphoma
formalin-fixed paraffin-embedded
rituximab
lenalidomide
stem cell transplantation
- 0 views
- 19 Feb, 2024